Cardiff Medicentre-based ultrasound training systems developer MedaPhor has grown turnover by more than 60 per cent in its half-year results, boosted by recovering US sales.

According to the listed company's results for the six months to 30 June 2017, revenue has grown to £2.1m, from £1.3m in the same period of 2016.

However, pre-tax losses widened to £1.3m from £998,612 the year before.

In the first quarter of the year, the year, MedaPhor settled its US litigation case and has benefitted from a recovery in US sales growth as a result.

The company also completed the first sales of its ScanTrainer product in India and began selling through its Chinese reseller network.

Riccardo Pigliucci, chairman of MedaPhor, said: "The group is now recovering from the impact of the legal action that was settled in Q1 this year and I am encouraged that the US team is back on track, with ScanTrainer sales in North America up 38 per cent on H2 2016 and in-line with H1 2016.

"The Rest of the World ScanTrainer market grew 18 per cent in H1, but the UK medical market is in a challenging period of budget restraints. Despite this, I am pleased to report that Inventive Medical, which we acquired in August last year, made a significant contribution with £1.1m sales of the HeartWorks simulator in the period across all territories and we look forward to making further progress in the second half of the year."